Alpha 2.0
Login Register
» Articles » PMID: 24781352

Safety of Pediatric HIV Elimination: the Growing Population of HIV- and Antiretroviral-exposed but Uninfected Infants

Overview
Journal PLoS Med
Specialty General Medicine
Date 2014 May 1
PMID 24781352
Citations 14
Authors
Lynne M Mofenson
D Heather Watts
Affiliations
Soon will be listed here.
Abstract

Lynne Mofenson and Heather Watts discuss the context and implications of the study by J. Sibuide and colleagues, which provides a detailed analysis of birth defects in infants with in utero antiretroviral drug exposure in the French Perinatal Cohort. Please see later in the article for the Editors' Summary.

Citing Articles

Antiretroviral Options and Treatment Decisions During Pregnancy.

Poliektov N, Badell M Paediatr Drugs. 2023; 25(3):267-282.

PMID: 36729360 DOI: 10.1007/s40272-023-00559-w.

Does antiretroviral therapy cause congenital malformations? A systematic review and meta-analysis.

Alemu F, Yalew A Epidemiol Health. 2021; 43:e2021008.

PMID: 33541012 PMC: 8060528. DOI: 10.4178/epih.e2021008.

Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?.

Fairlie L, Waitt C, Lockman S, Moorhouse M, Abrams E, Clayden P J Int AIDS Soc. 2019; 22(9):e25372.

PMID: 31529598 PMC: 6747006. DOI: 10.1002/jia2.25372.

HIV in pregnancy: Identification of intrapartum and perinatal HIV exposures.

Moore D, Allen U Paediatr Child Health. 2019; 24(1):42-49.

PMID: 30833819 PMC: 6376313. DOI: 10.1093/pch/pxy181.

In Utero ART Exposure and Birth and Early Growth Outcomes Among HIV-Exposed Uninfected Infants Attending Immunization Services: Results From National PMTCT Surveillance, South Africa.

Ramokolo V, Goga A, Lombard C, Doherty T, Jackson D, Engebretsen I Open Forum Infect Dis. 2017; 4(4):ofx187.

PMID: 29062860 PMC: 5641411. DOI: 10.1093/ofid/ofx187.

References
1.
Townsend C, Byrne L, Cortina-Borja M, Thorne C, de Ruiter A, Lyall H . Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011. AIDS. 2014; 28(7):1049-57. DOI: 10.1097/QAD.0000000000000212. View
2.
Cooper E, Charurat M, Mofenson L, Hanson I, Pitt J, Diaz C . Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002; 29(5):484-94. DOI: 10.1097/00126334-200204150-00009. View
3.
Brogly S, Abzug M, Watts D, Cunningham C, Williams P, Oleske J . Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. Pediatr Infect Dis J. 2010; 29(8):721-7. PMC: 2948952. DOI: 10.1097/INF.0b013e3181e74a2f. View
4.
Boyd P, Haeusler M, Barisic I, Loane M, Garne E, Dolk H . Paper 1: The EUROCAT network--organization and processes. Birth Defects Res A Clin Mol Teratol. 2011; 91 Suppl 1:S2-15. DOI: 10.1002/bdra.20780. View
5.
Sibiude J, Mandelbrot L, Blanche S, Chenadec J, Boullag-Bonnet N, Faye A . Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11). PLoS Med. 2014; 11(4):e1001635. PMC: 4004551. DOI: 10.1371/journal.pmed.1001635. View